Other OTC - Delayed Quote USD

Theralink Technologies, Inc. (THER)

0.0010 -0.0003 (-23.08%)
At close: April 26 at 3:23 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Faith Zaslavsky President & CEO 404.55k -- 1973
Mr. Andrew Albert Kucharchuk M.B.A. CFO & Director 222.87k -- 1981
Dr. Michael I. Ruxin M.D. Chief Medical Officer & Director 1.16M -- 1946
Mr. Trevor McCartney VP of Sales Operations & Strategic Partnerships -- -- --

Theralink Technologies, Inc.

15000 West 6th Avenue
Suite 400
Golden, CO 80401
United States
888 585 4923 https://www.theralink.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
16

Description

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. In addition, the company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. The company was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies, Inc.is headquartered in Golden, Colorado.

Corporate Governance

Theralink Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 01, 2024 - May 05, 2024
Theralink Technologies, Inc. Earnings Call

Related Tickers

NKGNW NKGen Biotech, Inc.
0.0858
-38.71%
 
20D.BE Cidara Therapeutics Inc
10.42
+1,900.00%
 
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
 
AAGH America Great Health
0.0008
+2.36%
 
CNBX CNBX Pharmaceuticals Inc.
0.0108
-16.92%
 
OCEAW Ocean Biomedical, Inc.
0.0800
-27.27%
 
TRML Tourmaline Bio, Inc.
15.68
-2.00%
 
CING Cingulate Inc.
0.8801
+1.71%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
0.2376
-0.50%
 
TENX Tenax Therapeutics, Inc.
3.4800
-0.85%